A Novel Diphenylthiosemicarbazide Is a Potential Insulin Secretagogue for Anti-Diabetic Agen.
Insulin secretagogues are used for treatment of type 2 diabetes. We attempted to discover novel small molecules to stimulate insulin secretion by using in silico similarity search using sulfonylureas as query, followed by measurement of insulin secretion. Among 38 compounds selected by in silico sim...
Main Authors: | Kenji Sugawara, Kohei Honda, Yoshie Reien, Norihide Yokoi, Chihiro Seki, Harumi Takahashi, Kohtaro Minami, Ichiro Mori, Akio Matsumoto, Haruaki Nakaya, Susumu Seino |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5072725?pdf=render |
Similar Items
-
Correction: A Novel Diphenylthiosemicarbazide Is a Potential Insulin Secretagogue for Anti-Diabetic Agent.
by: PLOS ONE Staff
Published: (2017-01-01) -
Essential roles of aspartate aminotransferase 1 and vesicular glutamate transporters in β-cell glutamate signaling for incretin-induced insulin secretion.
by: Naoya Murao, et al.
Published: (2017-01-01) -
A protective role of Nox1/NADPH oxidase in a mouse model with hypoxia-induced bradycardia
by: Akiteru Kojima, et al.
Published: (2015-03-01) -
Increased glycolysis affects β-cell function and identity in aging and diabetes
by: Naoya Murao, et al.
Published: (2022-01-01) -
Inhibition of ATP-Sensitive K+ Channels and L-Type Ca2+ Channels by Amiodarone Elicits Contradictory Effect on Insulin Secretion in MIN6 Cells
by: Atsushi Nishida, et al.
Published: (2011-01-01)